NCT02071914 A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model Status COMPLETED Phase PHASE2
NCT01873443 Long-Term Efficacy and Safety of CT-P10 in Patients With RA Status COMPLETED Phase PHASE1
NCT01571219 An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1 Status COMPLETED Phase PHASE3
NCT01571206 An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1 Status COMPLETED Phase PHASE1
NCT01534949 Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial Status TERMINATED Phase PHASE1
NCT01534884 Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01220518 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) Status COMPLETED Phase PHASE1
NCT01217086 Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA) Status COMPLETED Phase PHASE3
NCT01084876 Demonstrate Efficacy and Safety of Metastatic Breast Cancer Status COMPLETED Phase PHASE3